• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Ontazolast

CAS No. 147432-77-7

Ontazolast ( —— )

产品货号. M36207 CAS No. 147432-77-7

Ontazolast is a small molecule leukotriene B4 receptor (LTB4R) antagonist for the treatment of immune system disorders and respiratory diseases.Ontazolast is a candidate compound for the treatment of asthma.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥1098 有现货
5MG ¥1696 有现货
10MG ¥2503 有现货
25MG ¥4583 有现货
50MG ¥6100 有现货
100MG ¥8339 有现货
500MG ¥16677 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Ontazolast
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Ontazolast is a small molecule leukotriene B4 receptor (LTB4R) antagonist for the treatment of immune system disorders and respiratory diseases.Ontazolast is a candidate compound for the treatment of asthma.
  • 产品描述
    Ontazolast is a small molecule leukotriene B4 receptor (LTB4R) antagonist for the treatment of immune system disorders and respiratory diseases.Ontazolast is a candidate compound for the treatment of asthma.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Immunology/Inflammation
  • 靶点
    LTR
  • 受体
    LTR
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    147432-77-7
  • 分子量
    335.44
  • 分子式
    C21H25N3O
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    N([C@@H](CC1CCCCC1)C2=CC=CC=N2)C=3OC=4C(N3)=CC(C)=CC4
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • LTB4-IN-1

    LTB4-IN-1 (Compound 6) 是白三烯 (LTB4) 合成抑制剂,IC50 为 70 nM。

  • Moxilubant HCl

    Moxilubant HCl is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis.

  • Ontazolast

    Ontazolast is a small molecule leukotriene B4 receptor (LTB4R) antagonist for the treatment of immune system disorders and respiratory diseases.Ontazolast is a candidate compound for the treatment of asthma.